Uncategorized
Aerie reports net loss for fourth quarter, full year
Aerie Pharmaceuticals reported a GAAP net loss of $10.3 million, or $0.62 per share, for the fourth quarter ending Dec. 31, 2013, bringing the year-end GAAP net loss to $31.6 million, or $6.38 per share, according to a press release. GAAP net loss was $3.8 million, or $4.01 per share, and $15.6 million, or $16.39 per share, for the respective time periods the prior year.